Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
Wake Forest University Health Sciences
Stanford University
University of Utah
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc